Ignite Creation Date:
2024-05-06 @ 12:12 AM
Last Modification Date:
2024-10-26 @ 10:46 AM
Study NCT ID:
NCT01510886
Status:
COMPLETED
Last Update Posted:
2014-08-13
First Post:
2012-01-12
Brief Title:
Assessment of MDD Management in Andalusia
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
Assessment of MDD Management Strategies in Andalusia A Sub-analysis of the PismaEP Study
Status:
COMPLETED
Status Verified Date:
2014-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PismaEP
Brief Summary:
The main objectives of this study are to describe medical professionals responsible of the management of patients with MDD in a representative region of Andalusia in terms of type of sites managing the disease and referral to SC criteria Describe MDD patient characteristics at inclusion in the PISMA-Ep Study and to evaluate those factors associated to a higher incidence of referral from PC to SC
Detailed Description:
Assessment of MDD management strategies in Andalusia A Sub-analysis of the PismaEP Study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| PismaEP | None | None | None |